Xcorporeal, Inc. XCRP

Company Overview

Xcorporeal, Inc. (OTC: XCRP) was a U.S.-based medical device company focused on extracorporeal blood filtration and renal support technologies. Historical public disclosures and archived market data indicate that the company developed systems intended to provide continuous blood purification therapies for patients suffering from acute kidney injury and fluid overload conditions, operating within the broader medical technology and renal care industries.

The company’s primary commercial focus centered on the development and potential commercialization of its extracorporeal therapy platform, including portable hemofiltration technologies designed for hospital and critical care environments. Available historical records suggest that Xcorporeal, Inc. pursued differentiation through compact device architecture and lower-flow blood filtration systems intended to simplify renal replacement therapy procedures. Publicly available information regarding the company’s later-stage operations, financial condition, or current commercial activity is limited, and some corporate status details are inconclusive based on available public sources.